Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Impact of Belatacept Conversion on Metabolic and Infectious Complications in Kidney Transplant Recipients at Grenoble-Alpes University Hospital

NCT05316038 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT05316038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05316038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Impact of Belatacept Conversion on Metabolic and Infectious Complications in Kidney Transplant Recipients at Grenoble-Alpes University Hospital
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2022
Completion date
June 1, 2024
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, immunosuppression, kidney transplant infection, kidney transplant; complications